These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 2412021)

  • 21. [Angiotensin-converting enzyme inhibition: direct and indirect mechanisms].
    Stumpe KO
    Klin Wochenschr; 1985 Sep; 63(18):897-906. PubMed ID: 2997540
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Moderate sodium restriction, angiotensin converting enzyme inhibition, and thiazide diuretic in the management of essential hypertension.
    Singer DR; Markandu ND; Furnival L; Khoshnodi L; MacGregor GA
    J Cardiovasc Pharmacol; 1989; 13 Suppl 3():S5-7. PubMed ID: 2474103
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Relationship between vasopressin and the renin-angiotensin-aldosterone system in essential hypertension: effect of converting enzyme inhibitor on plasma vasopressin.
    Santucci A; Leonetti Luparini R; Ferri C; Ficara C; Giarrizzo C; Balsano F
    J Hypertens Suppl; 1985 Nov; 3(2):S133-4. PubMed ID: 3003302
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Renin- and non-renin-mediated antihypertensive actions of converting enzyme inhibitors.
    Zusman RM
    Kidney Int; 1984 Jun; 25(6):969-83. PubMed ID: 6088887
    [No Abstract]   [Full Text] [Related]  

  • 25. Hormonal and metabolic effects of angiotensin converting enzyme inhibitors. Possible differences between enalapril and captopril.
    Atlas SA; Case DB; Yu ZY; Laragh JH
    Am J Med; 1984 Aug; 77(2A):13-7. PubMed ID: 6089554
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Renin, calcium metabolism and the pathophysiologic basis of antihypertensive therapy.
    Resnick LM; Laragh JH
    Am J Cardiol; 1985 Dec; 56(16):68H-74H. PubMed ID: 2866707
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Captopril versus enalapril maleate: a comparison of antihypertensive and hormonal effects.
    Lewis RA; Baker KM; Ayers CR; Weaver BA; Lehman MR
    J Cardiovasc Pharmacol; 1985; 7 Suppl 1():S12-5. PubMed ID: 2580164
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Single administration of captopril and combined use with beta-blocker and/or thiazide diuretic in the treatment of essential hypertension.
    Yoneda S; Kako T; Koketsu M; Hayano J; Asakawa T; Fujinami T; Kato T
    Angiology; 1991 Nov; 42(11):914-23. PubMed ID: 1683186
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [A new principle in long-term treatment of essential hypertension: angiotensin-converting enzyme inhibition (author's transl)].
    Overlack A; Stumpe KO; Heck I; Krück F
    Dtsch Med Wochenschr; 1980 Apr; 105(15):505-9. PubMed ID: 6244920
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Treatment of drug-resistant hypertension with minoxidil or angiotensin-converting enzyme inhibitor: blood pressure, renin, aldosterone, and electrolyte responses.
    Baer L; Radichevich I; Williams GS
    J Cardiovasc Pharmacol; 1980; 2 Suppl 2():S206-16. PubMed ID: 6156357
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Non-sulfhydryl-containing angiotensin-converting enzyme inhibitor (MK421): evidence for role of renin system in normotensive subjects.
    MacGregor GA; Markandu ND; Bayliss J; Roulston JE; Squires M; Morton JJ
    Br Med J (Clin Res Ed); 1981 Aug; 283(6288):401-3. PubMed ID: 6266576
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Blood pressure effects of acute intravenous renin or oral angiotensin converting enzyme inhibition in essential hypertension.
    Azizi M; Guyene TT; Chatellier G; Ménard J
    J Hypertens; 1994 Apr; 12(4):419-27. PubMed ID: 8064166
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [New therapeutic approaches to arterial hypertension].
    Waeber B; Brunner HR
    Schweiz Med Wochenschr; 1982 Sep; 112(39):1330-4. PubMed ID: 6755692
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prolonged converting enzyme inhibition in non-modulating hypertension.
    Dluhy RG; Smith K; Taylor T; Hollenberg NK; Williams GH
    Hypertension; 1989 Apr; 13(4):371-7. PubMed ID: 2538393
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Renal artery stenosis with normal angiotensin II values. Relationship between angiotensin II and body sodium and potassium on correction of hypertension by captopril and subsequent surgery.
    Atkinson AB; Brown JJ; Davies DL; Leckie B; Lever AF; Morton JJ; Robertson JI
    Hypertension; 1981; 3(1):53-8. PubMed ID: 7009427
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Rate of activation of renin-angiotensin-aldosterone axis and sodium intake in rats.
    Holtzman E; Braley LM; Menachery A; Williams GH; Hollenberg NK
    Am J Physiol; 1989 May; 256(5 Pt 2):H1311-5. PubMed ID: 2655479
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of converting enzyme inhibition on blood pressure, plasma renin activity (PRA) and plasma aldosterone in hypertensive diabetics compared to patients with essential hypertension.
    Sullivan PA; Kelleher M; Twomey M; Dineen M
    J Hypertens; 1985 Aug; 3(4):359-63. PubMed ID: 2995484
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Role of kallikrein-kinin system in the hypotensive mechanisms of converting enzyme inhibitors in essential hypertension.
    Iimura O; Shimamoto K
    J Cardiovasc Pharmacol; 1989; 13 Suppl 3():S63-6. PubMed ID: 2474107
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Converting enzyme inhibitors normalize the reduced adrenal responsiveness to angiotensin II in essential hypertension.
    Williams GH; Hollenberg NK
    J Hypertens Suppl; 1984 Dec; 2(2):S43-7. PubMed ID: 6100876
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Inhibitors of the renin-angiotensin system. Effects on blood pressure, aldosterone secretion and renal function.
    Atlas SA; Niarchos AP; Case DB
    Am J Nephrol; 1983; 3(2-3):118-27. PubMed ID: 6191567
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.